MyFinsight
Home
Blog
About
Inventories, net
$303,600K
(-10.34%↓ Y/Y)
Accounts receivable, net
$190,000K
(138.10%↑ Y/Y)
Cash and cash
equivalents
$139,700K
(-47.74%↓ Y/Y)
Prepaid expenses and
other current assets
$25,400K
(5.83%↑ Y/Y)
Assets held-for-sale
$6,100K
(0.00%↑ Y/Y)
Restricted cash
$1,200K
(-67.57%↓ Y/Y)
Total current assets
$666,000K
(-7.44%↓ Y/Y)
Intangible assets, net
$261,800K
(-44.18%↓ Y/Y)
Property, plant and
equipment, net
$178,000K
(-17.63%↓ Y/Y)
Other assets
$11,000K
(-12.00%↓ Y/Y)
Total assets
$1,116,800K
(-21.19%↓ Y/Y)
Total liabilities and
stockholders equity
$1,116,800K
(-21.19%↓ Y/Y)
Total liabilities
$775,400K
(-11.98%↓ Y/Y)
Total stockholders
equity
$341,400K
(-36.33%↓ Y/Y)
Accumulated deficit
-$333,200K
(-113.04%↓ Y/Y)
Treasury stock, at cost,
10.7 and 8.7 common...
$270,500K
(15.30%↑ Y/Y)
Accumulated other
comprehensive loss, net
-$6,800K
(16.05%↑ Y/Y)
Debt
$581,800K
(-12.88%↓ Y/Y)
Total current
liabilities
$122,800K
(-3.38%↓ Y/Y)
Other liabilities
$35,400K
(-10.38%↓ Y/Y)
Deferred tax liability
$35,400K
(-23.87%↓ Y/Y)
Additional paid-in capital
$951,800K
(1.78%↑ Y/Y)
Common stock, 0.001 par
value per share 200.0...
$100K
(0.00%↑ Y/Y)
Accounts payable
$50,200K
(-21.19%↓ Y/Y)
Accrued compensation
$26,200K
(-16.83%↓ Y/Y)
Accrued expenses
$17,100K
(25.74%↑ Y/Y)
Deferred revenue
$15,000K
Other current
liabilities
$9,900K
(-27.21%↓ Y/Y)
Current tax liability
$4,400K
Back
Back
Balance Sheet
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)
source: myfinsight.com